Role of itraconazole in haematology/oncology.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12598396.
- Also identified by PMC identifier 1719494.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The antifungal agents most frequently used in prophylaxis and treatment are amphotericin B (and its new lipid forms) and azoles such as fluconazole, itraconazole, and more recently voriconazole. This review assesses the role of itraconazole in paediatric haematology/oncology practice. Its broader spectrum of activity and availability in oral and intravenous forms allow a flexible approach in the management of fungal infections.
Medical subject headings
- Antifungal Agents
- Itraconazole
- Mycoses